SciELO - Scientific Electronic Library Online

 
vol.24 número12Reacciones adversas a medicamentos en pacientes que acudieron a un hospital general: un meta-análisis de resultados índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

  • En proceso de indezaciónCitado por Google
  • No hay articulos similaresSimilares en SciELO
  • En proceso de indezaciónSimilares en Google

Compartir


Anales de Medicina Interna

versión impresa ISSN 0212-7199

Resumen

CALVO ROMERO, J. M.  y  LIMA RODRIGUEZ, E. M.. Cancer in patients with venous thromboembolic disease. An. Med. Interna (Madrid) [online]. 2007, vol.24, n.12, pp.571-573. ISSN 0212-7199.

Objective: To study the characteristics of patients with venous thromboembolic disease (VTD) and cancer in our area. Methods: Prospective observational study of all patients diagnosed by objective methods of VTD in the only hospital in a rural area from November 2002 to April 2005. Results: Ninety-four patients were diagnosed of VTD. The median age was 71.9 years (range 35-94 years), and 52 (55.3%) were women. The median follow-up with anticoagulant therapy was 7.1 months (range 0-29 months). Seventeen patients (18.1%) had cancer. Eleven cases (64.7%) had an adenocarcinoma, and 7 (41.2%) had distant metastases. Two (2.5%) of 79 cases without prior cancer were diagnosed of cancer after the diagnosis of VTD. The frequency of adverse events (death, major hemorrhage and thromboembolic recurrence) was higher in patients with cancer (64.7 vs. 9.1%, p < 0.001). Conclusions: Almost one fifth of patients with VTD in our area had cancer, more frequently an adenocarcinoma. Cancer is infrequently diagnosed after the diagnosis of VTD. Cancer in VTD is associated to a poor prognosis, with a remarkable frequency of adverse events.

Palabras clave : Cancer; Venous thromboembolic disease; Venous thromboembolism.

        · resumen en Español     · texto en Español     · Español ( pdf )

 

Creative Commons License Todo el contenido de esta revista, excepto dónde está identificado, está bajo una Licencia Creative Commons